Search Results - Shereen Hammad

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Efficacy and safety of upadacitinib through 140 weeks in Chinese adult and adolescent patients with moderate-to-severe atopic dermatitis: Post hoc analysis of the phase 3 Measure Up 1 and AD Up clinical trials

    Efficacy and safety of upadacitinib through 140 weeks in Chinese adult and adolescent patients with moderate-to-severe atopic dermatitis: Post hoc analysis of the phase 3 Measure U... by Li Zhang, Jinhua Xu, Chaoying Gu, Min Zheng, Meng Pan, Linfeng Li, Michael Lane, Andrew Platt, Shereen Hammad, Qichen Fan, Xinghua Gao, Lishao Guo

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: